‘The only living worker left’.
The government’s ‘levelling up’ agenda seems to be taking no account of coming automation.
Staff members work at a COVID-19 vaccine-producing plant of Sinovac in Beijing.
Zhang Yuwei/Xinhua via Getty
Local companies in Africa would find it very challenging to be cost-competitive in the longer run when the current worldwide scarcity of COVID-19 vaccines is overcome.
Factory robots could soon acquire a range of skills, including the ability to choose how to make things.
studiostockart/DigitalVision Vectors via Getty Images
Custom fabrication involves taking measurements, choosing tools, deciding on sequences of steps and ordering from a menu of materials. AIs under development promise to take humans out of the loop.
Australia’s abundant wind and solar resources mean we’re well placed to produce the hydrogen a green steel industry needs. But there are technical and economic challenges ahead.
Office of the Chief Scientist
Chief Scientist Cathy Foley says high-tech manufacturing is the way forward for Australia.
Textile workers at the Fine Spinners clothing factory in Uganda.
Industrialisation was key to long-term economic growth in the west and Asia. After years of going in the wrong direction, new research suggests that many African countries have seen a turnaround.
Face masks are seen in the window of a shop during the COVID-19 pandemic in Montréal in December 2020.
THE CANADIAN PRESS/Paul Chiasson
Whether it’s health-care workers, kids in school or people running errands, Canadians need face masks during COVID-19. There’s no reason they shouldn’t be made here at home.
The EUV-SK1, developed by One Health Medical Technologies with subject matter experts from the University of Saskatchewan.
(RMD Engineering, Inc.)
How a veterinarian and a law professor joined a multidisciplinary team to help produce a made-in-Saskatchewan emergency-use ventilator during the COVID-19 pandemic.
University of Canberra Professorial Fellow Michelle Grattan and University of Canberra Assistant Professor Caroline Fisher discuss the week in politics.
In the wake of the pandemic, Anthony Albanese is struggling to find any political chances.
Increased automation threatens job security in South Africa’s auto industry.
Michael Sheehan/picture alliance via Getty Images
Automation in South Africa’s auto industry may have made car manufacturing easier, faster, and more productive but it comes with social and employment costs.
The federal government is selecting six priority areas for support in a $1.5 billion manufacturing plan Scott Morrison will outline in a pre-budget address.
It’s encouraging that the federal government recognises its role in industry policy. But its choice to support some technologies is disappointing.
Digitising healthcare and exporting more sustainable protein alternatives are just some ideas that could help Australia’s economy return to form.
The global pandemic has interrupted supply chains for almost 75% of US companies.
Thatree Thitivongvaroon/Getty Images
Medical supply shortages during the pandemic revealed that US industries are unable to provide essential goods in a crisis. A return to domestic production would boost incomes and prepare us for the next crisis.
Billions of people are going to need a coronavirus vaccine and that demand is going to be hard to meet.
Francesco Carta fotografo/Moment via Getty Images
Once a coronavirus vaccine is approved, billions of doses need to be manufactured. Current vaccine production is nowhere near ready, for a variety of reasons, but planning now could help.
Szasz-Fabian Ilka Erika/Shutterstock
New manufacturing processes will revolutionise the way we take our medicines.
Workers with face masks seen at The Hat Factory in Cape Town, South Africa. But most employers don’t abide by health and safety regulations.
Nardus Engelbrecht/Gallo Images via Getty Images
Compliance with occupational health and safety requirements is already poor and few inspections of workplaces are being done.
COVID-19 is forcing us to look at business differently.
The UK is investing heavily in preparation for mass manufacturing of a working COVID-19 vaccine.